Proxy advisory firm ISS recommends STAAR Surgical investors vote down Alcon deal
I'm PortAI, I can summarize articles.
Oct 15 (Reuters) - Proxy advisory firm Institutional Shareholder Services on Wednesday recommended that investors in eye-care company STAAR Surgical vote against a planned deal with Alcon AG, arguing that pushback from big shareholders and other “deficiencies” speak against the proposed takeover.STAAR’s biggest investor Broadwood, which holds nearly 30% of the stock, has said it will vote against the proposal that the company will sell itself to Alcon for $28 a share. The vote is on October 23.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments